Results 131 to 140 of about 75,183 (262)

Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia

, 2020
Stacy Tressler, Christa Lilly, Diane Gross, Thomas C. Hulsey, Judith Feinberg   +4 more
openalex   +2 more sources

Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell Disease

Transplant Infectious Disease, EarlyView.
At baseline, 55% of sickle cell patients showed HBV immunity, and 93% received post HCT revaccination, with 89% completing the series. Between Years 1–2, 67.5% of vaccinated patients had rising anti HBs titers. No HBV reactivation occurred, though nonresponders under heavy immunosuppression need further study.
Henna Butt, Neal Jeffries, Triscia Martin, Valeria De Giorgi, Alison Zamora, John F. Tisdale, Matthew M. Hsieh   +6 more
wiley   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

International Journal of Cancer, Volume 158, Issue 4, Page 909-923, 15 February 2026.
What's new? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang   +17 more
wiley   +1 more source

Hepatitis B vaccine and neurotoxicity [PDF]

Postgraduate Medical Journal, 1997
M, Pirmohamed, P, Winstanley
openaire   +2 more sources

Bee products as alternatives in the treatment of viral infections

Journal of the Science of Food and Agriculture, Volume 106, Issue 1, Page 33-54, 15 January 2026.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba, Łukasz Marek, Jerzy Stojko, Anna Rzepecka‐Stojko   +3 more
wiley   +1 more source

Evaluation of the efficacy of hepatitis B vaccine in different age groups of vaccinated children in Egypt

, 2016
Ahmed Mohamed Tammam Abdelgawad, Abdelmoneam Hosni   +1 more
openalex   +1 more source

Hepatitis Vaccines: Recent Advances and Challenges. [PDF]

Vaccines (Basel)
Lu M, Liu Y, Li L, Liu X, Wu B, Wu Y.
europepmc   +1 more source

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

Cancer, Volume 132, Issue 1, 1 January 2026.
Abstract Background Eligibility criteria for clinical trials are crucial for maintaining safety and study integrity. However, overly restrictive criteria can result in unrepresentative trial populations, leading to gaps in understanding real‐world treatment efficacy.
Fen Saj, Felicity K. Namayanja, Lianchun Xiao, Mitesh J Borad, Robin Kate Kelley, Lipika Goyal, Nilofer S. Azad, Melinda Bachini, Stacie Lindsey, Shubham Pant, Juan W. Valle, Lola A Fashoyin‐Aje, Milind Javle   +12 more
wiley   +1 more source

Influences of obesity on the immunogenicity of Hepatitis B vaccine [PDF]

, 2017
Fang Liu, Zhirong Guo, Chen Dong
openalex   +1 more source

Comparison of safety and immunogenicity between Healive®, Havrix® and live attenuated Hepatitis A vaccines in pediatric population: a systematic review with meta-analysis. [PDF]

Ital J Pediatr
Abo Zeid M, Elrosasy A, Farho MA, Rifai M, Aboelkhier MM, Elkhrashy MN, Zabady AH, Zaki MSA, Hamed EM, Dawood SA, Abuzaid Y.   +10 more
europepmc   +1 more source